Plasma YKL-40 concentration was in the linear correlation to the severity of AKI and proinflammatory markers, with a cut-off concentration > 142 μg/L being predictor of adverse outcomes and mortality (37, 91). The gene discussed is CHI3L1; the disease is acute kidney injury.